The significance of oligoclonal bands in multiple sclerosis in Japan: Relevance of immunogenetic backgrounds

Journal of the Neurological Sciences

Volumn 158, Issue 2, 1998, Pages 209-214

  Fukazawa, T ^a   Kikuchi, S ^b   Sasaki, H ^b   Hamada, K ^a   Hamada, T ^a   Miyasaka, K ^b   Tashiro, K ^b  

^a Hokuyukai Neurology Hospital   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

HLA; Immunogenetics; Japanese; Multiple sclerosis; Oligoclonal IgG bands

Indexed keywords

ANTIGEN RECOGNITION; ARTICLE; HLA SYSTEM; HUMAN; HUMORAL IMMUNITY; IMMUNOGENETICS; JAPAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

ADULT; ANTIBODIES, ANTINUCLEAR; FEMALE; HLA ANTIGENS; HLA-DR2 ANTIGEN; HLA-DR4 ANTIGEN; HUMANS; IMMUNOGENETICS; IMMUNOGLOBULINS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OLIGOCLONAL BANDS;

EID: 0032581195     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00127-0     Document Type: Article

References (34)

1. Andersson M., Alvarez-Cermeno J., Bernardi G.et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J. Neurol. Neurosurg. Psychiatry. 57:1994;897-902.
2. Baumhefner R.W., Tourtellotte W.W., Syndulko K.et al. Quantitative multiple sclerosis plaque assessment with magnetic resonance imaging: its correlation with clinical parameters, evoked potentials, and intra-blood-brain barrier IgG synthesis. Arch. Neurol. 47:1990;19-26.
3. Farrell M.A., Kaufmann J.C.E., Gilbert J.J., Noseworthy J.H., Armstrong H.A., Ebers G.C. Oligoclonal bands in multiple sclerosis: clinical-pathologic correlation. Neurology. 35:1985;212-218.
4. Fazekas F., Offenbacher H., Schmidt R.et al. MRI of neuromyelitis optica: evidence for a distinct entity. J. Neurol. Neurosurg. Psychiatry. 57:1994;1140-1142.
5. Fieschi C., Gasperini C., Ristori G.et al. Patients with clinically definite multiple sclerosis, white matter abnormalities on MRI, and normal CSF: if not multiple sclerosis, what is it? J. Neurol. Neurosurg. Psychiatry. 58:1995;255-256.
6. Fukazawa T., Hamada T., Tashiro K.et al. Acute transverse myelopathy in multiple sclerosis. J. Neurol. Sci. 100:1990;217-222.
7. Fukazawa T., Tashiro K., Hamada T.et al. Multiple sclerosis in Hokkaido, the northernmost island of Japan: prospective analyses of clinical features. Intern. Med. 31:1992;349-352.
8. Fukazawa T., Miyasaka K., Tashiro K.et al. MRI findings of multiple sclerosis with acute transverse myelopathy. J. Neurol. Sci. 110:1992;27-31.
9. Fukazawa T., Hamada T., Tashiro K.et al. HLA profiles of multiple sclerosis in Hokkaido, the northernmost island of Japan. Acta Neurol. Scand. 86:1992;517-520.
10. Fukazawa T., Moriwaka F., Sugiyama K.et al. Cerebrospinal fluid IgG profiles and multiple sclerosis in Japan. Acta Neurol. Scand. 88:1993;178-183.
11. Fukazawa T., Moriwaka F., Mukai M.et al. Anticardiolipin antibodies in Japanese patients with multiple sclerosis. Acta Neurol. Scand. 88:1993;184-189.
12. Fukazawa T., Hamada T., Moriwaka F.et al. Acute transverse myelopathy in MS: clinical considerations. Int. MS J. 1:1994;26-33.
13. Fukazawa T., Hamada T., Kikuchi S.et al. Antineutrophil cytoplasmic antibodies and the optic-spinal cord of multiple sclerosis in Japan. J. Neurol. Neurosurg. Psychiatry. 61:1996;203-204.
14. Hashimoto M., Kinoshita T., Yamasaki M.et al. Gene frequencies and haplotypic associations within the HLA region in 916 unrelated Japanese individuals. Tissue Antigens. 44:1994;166-173.
15. Hillert J. Human leukocyte antigen studies in multiple sclerosis. Ann. Neurol. 36:1994;S15-S17.
16. Kira J., Kanai T., Nishimuta Y.et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann. Neurol. 40:1996;569-574.
17. Link H. The cerebrospinal fluid in multiple sclerosis. In: Swash M, Oxbury J, editors. Clinical Neurology. Edinburgh: Churchill Livingstone, 119:1128-1138.
18. Mandler R.N., Davis L.E., Jeffery D.R.et al. Devic's neuromyelitis optica: a clinicopathological study of eight patients. Ann. Neurol. 34:1993;162-168.
19. Müller F.A.J., Hänny P.E., Wichmann W.et al. Cerebrospinal fluid immunoglobulins and multiple sclerosis: correspondence with magnetic resonance imaging and visually evoked potential changes. Arch. Neurol. 46:1989;367-371.
20. O'Riordan J.I., Gallagher H.L., Thompson A.J.et al. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J. Neurol. Neurosurg. Psychiatry. 60:1996;382-387.
21. Pender M.P., Greer J.M., Csurbes P.A.et al. T-cell reactivity to peptides of proteolipid protein and myelin basic protein in multiple sclerosis. Ann. Neurol. 40:1996;552.
22. Pittilä T., Nurmikko T. CSF oligoclonal bands, MRI, and the diagnosis of multiple sclerosis. Acta Neurol. Scand. 92:1995;468-471.
23. Poser C.M., Paty D.W., Scheinberg L.et al. New diagnostic criteria for multiple sclerosis: guideline for research protocols. Ann. Neurol. 13:1983;227-231.
24. Rudick R.A., Schiffer R.B., Schwetz K.M.et al. Multiple sclerosis: the problem of incorrect diagnosis. Arch. Neurol. 43:1986;578-583.
25. Schuurs A., Verheul H. Effects of gender and sex steroids on the immune response. J. Steroid Biochem. 35:1990;157-172.
26. Shibasaki H., McDonald W.I., Kuroiwa Y. Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients. J. Neurol. Sci. 49:1981;253-271.
27. Stendahl-Brodin L., Link H. Relation between benign course of multiple sclerosis and low-grade humoral immune response in cerebrospinal fluid. J. Neurol. Neurosurg. Psychiatry. 43:1980;102-105.
28. Tabira T, Johnson KP, Vandvic B, Iwashita H. CSF immunoglobulin and virus antibody in Japanese MS: a comparative study. In: Kuroiwa Y, Kurland L, editors. Multiple sclerosis. Kyushu: Kyushu University Press, 1982:223-233.
29. Tourtellotte WW. The cerebrospinal fluid in multiple sclerosis. In: Bruyn G, editor. Handbook of clinical neurology. Vol 3 (47). Demyelinating diseases. Amsterdam: Elsevier: 1988:79-1302.
30. Tourtellotte W.W., Baumhefner R.W., Syndulko K.et al. The long march of the cerebrospinal fluid profile indicative of clinical definite multiple sclerosis; and still marching. J. Neuroimmunol. 20:1988;217-227.
31. Vernant J.-C., Cabre P., Smadja D.et al. Recurrent optic neuromyelitis with endocrinopathies: a new syndrome. Neurology. 48:1997;58-64.
32. Walsh M.J., Tourtellotte W.W. Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA and IgM in multiple sclerosis. J. Exp. Med. 163:1986;41-53.
33. Xu X.-H., McFarlin D.E. Oligoclonal bands in CSF: twins with MS. Neurology. 34:1984;769-774.
34. Zeman A.Z.J., Kidd D., McLean B.N.et al. A study of oligoclonal band negative multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 60:1996;27-30.